Ocular gene therapy using avalanchemediated transfection

Details for Australian Patent Application No. 2006279395 (hide)

Owner The Board of Trustees of the Leland Stanford Junior University

Inventors Blumenkranz, Mark; Chalberg, Thomas W. Jr.; Marmor, Michael F.; Palanker, Daniel V.; Vankov, Alexander; Huie, Philip Jr; Calos, Michele P.

Agent Eagar & Buck

Pub. Number AU-A-2006279395

PCT Pub. Number WO2007/022403

Priority 11/360,984 22.02.06 US; 60/708,486 15.08.05 US

Filing date 15 August 2006

Wipo publication date 22 February 2007

International Classifications

C12N 15/87 (2006.01) Mutation or genetic engineering - Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation

Event Publications

6 March 2008 PCT application entered the National Phase

  PCT publication WO2007/022403 Priority application(s): WO2007/022403

15 March 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006279400-Combination methods of SAHA and Targretin for treating cancer

2006279376-Pyrazine kinase inhibitors